South Korea-based Samyang Biopharm, specializing in medical devices, has selected Hungary for its first production unit in Europe. The HUF 8.6 billion (EUR 26.2 million) unit, will produce synthetic suture materials and create 55 new jobs in Gödöllő. The Hungarian government contributes about 15% of that amount (HUF 1.3 billion) in non-refundable support. The South […]
